COMPARISON OF DOSE ESCALATION OF INFLIXIMAB AND THE ADDITION OF TACROLIMUS IN RHEUMATOID ARTHRITIS PATIENTS WITH AN INADEQUATE RESPONSE TO INFLIXIMAB AND METHOTREXATE COMBINATION THERAPY

被引：0
|
作者：
Yonemoto, Y. [1 ]
Okamura, K. [1 ]
Kaneko, T. [1 ]
Kobayashi, T. [1 ]
Takagishi, K. [1 ]
机构：
[1] Gunma Univ, Grad Sch Med, Dept Orthopaed Surg, Maebashi, Gunma 371, Japan
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2013年 / 71卷
关键词：
D O I：
10.1136/annrheumdis-2012-eular.2097
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：199 / 200
页数：2
相关论文
共 50 条
  • [41] Infliximab therapy leads to clinical and radiographic benefits in early rheumatoid arthritis patients receiving optimum methotrexate dose
    Bathon, J
    Devogelaer, J
    Kalden, JR
    Shiff, M
    Emery, P
    Maini, RN
    van der Heijde, D
    Keystone, E
    Baker, D
    Patel, K
    Han, J
    Smolen, J
    Clair, EWS
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 293 - 293
  • [42] Renal function in rheumatoid arthritis patients treated with methotrexate and infliximab
    Wiland, P
    Wiela-Hojenska, A
    Glowska, A
    Chlebicki, A
    Hurkacz, M
    Orzechowska-Juzwenko, K
    Szechinski, J
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2004, 22 (04) : 469 - 472
  • [43] Renal function in rheumatoid arthritis patients treated with methotrexate and infliximab
    Wiland, P
    Wiela-Hojenska, A
    Glowska, A
    Chlebicki, A
    Hurkacz, M
    Orzechowska-Juzwenko, K
    Szechinski, J
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 177 - 177
  • [44] MHC association with response to infliximab therapy in rheumatoid arthritis patients.
    Fernandez-Gutierrez, B
    Martinez, A
    Salido, M
    Bonilla, G
    Pascual-Salcedo, D
    de la Concha, EG
    ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S128 - S128
  • [45] THE EFFECTIVENESS OF SHORTENING INTERVALS OF INFLIXIMAB AND DOSE ESCALATION OF INFLIXIMAB WITH RHEUMATOID ARTHRITIS IN MULTI-CENTER CLINICAL PRACTICE
    Funahashi, K.
    Kojima, T.
    Takahashi, N.
    Kato, D.
    Matsubara, H.
    Hattori, Y.
    Ishiguro, N.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 367 - 368
  • [46] Baseline tumour necrosis factor alpha levels predict the necessity for dose escalation of infliximab therapy in patients with rheumatoid arthritis
    Takeuchi, Tsutomu
    Miyasaka, Nobuyuki
    Tatsuki, Yoshihiko
    Yano, Toshiro
    Yoshinari, Toru
    Abe, Tohru
    Koike, Takao
    ANNALS OF THE RHEUMATIC DISEASES, 2011, 70 (07) : 1208 - 1215
  • [47] Pressure pain thresholds in patients with rheumatoid arthritis after treatment with a combination of methotrexate and infliximab.
    Nordahl, S.
    Alstergren, P.
    Bratt, J.
    Ernestam, S.
    Kopp, S.
    JOURNAL OF DENTAL RESEARCH, 2003, 82 : B368 - B368
  • [48] Comment on methotrexate pneumonitis after initiation of infliximab therapy for rheumatoid arthritis
    Courtney, PA
    Alderdice, J
    Whitehead, EM
    ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2003, 49 (04): : 617 - 617
  • [49] Safety of leflunomide plus infliximab combination therapy in rheumatoid arthritis
    Godinho, F
    Godfrin, B
    El Mahou, S
    Navaux, F
    Zabraniecki, L
    Cantagrel, A
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2004, 22 (03) : 328 - 330
  • [50] Clinical aspects of infliximab and leflunomide combination therapy in rheumatoid arthritis
    Sidenco, Elena-Luminita
    Tugui, R.
    Chijan, D.
    Mitache, E.
    INFLAMMATION RESEARCH, 2007, 56 : S449 - S449
12345